HCV often remains asymptomatic for years, making early detection challenging. Screening helps identify infected individuals who can benefit from antiviral treatments, which can significantly reduce the risk of liver-related complications. Moreover, identifying and treating HCV-positive individuals decreases the overall disease burden and transmission rates in the population.